Literature DB >> 2907814

Transplant improves hemiparkinsonian syndrome in nonhuman primate: intracerebral injection, rotometry, tyrosine hydroxylase immunohistochemistry.

M Dubach, R H Schmidt, R Martin, D C German, D M Bowden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2907814     DOI： 10.1016/s0079-6123(08)60322-2

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN： 0079-6123            Impact factor:   2.453


× No keyword cloud information.
  5 in total

1.  MPTP induced hemiparkinsonism in monkeys: behavioral, mechanographic, electromyographic and immunohistochemical studies.

Authors:  A Benazzouz; C Gross; J Dupont; B Bioulac
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

Review 2.  Cell-based therapies for Parkinson's disease: past, present, and future.

Authors:  Kathleen M Fitzpatrick; James Raschke; Marina E Emborg
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

3.  Behavioral assessment of the ability of intracerebral embryonic neural tissue grafts to ameliorate the effects of brain damage in marmosets.

Authors:  R M Ridley; H F Baker; L E Annett; S B Dunnett; E M Torres; A Fine
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

Review 4.  The role of nonhuman primate models in the development of cell-based therapies for Parkinson's disease.

Authors:  Scott C Vermilyea; Marina E Emborg
Journal:  J Neural Transm (Vienna)       Date:  2017-03-22       Impact factor: 3.575

5.  Studies in neurobiology and aging at the United States National Institutes of health-sponsored regional primate research centers.

Authors:  F A King; C J Yarbrough
Journal:  Am J Primatol       Date:  1994       Impact factor: 2.371
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.